Source:http://linkedlifedata.com/resource/pubmed/id/11104510
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2000-12-20
|
pubmed:abstractText |
The C57BL/6 mice strain is known to be reputedly resistant to induction of experimental autoimmune neuritis (EAN), an animal model of Guillain-Barré syndrome in human by bovine peripheral myelin (BPM), and P2 protein or the P2 protein peptide 57-81. The P0 peptide 180-199 is a stronger neuritogenic antigen than the P2 peptide 57-81. We found that this synthetic peptide induced both clinical and pathological characteristics of an acute monophasic EAN in C57BL/6 mice. Only male mice were more sensitive to EAN induction with the P0 peptide 180-199. Intravenously administrated pertussis toxin (PT) had an adjuvant effect that increased the incidence of P0 peptide 180-199-induced EAN as well as the inflammation and demyelination in the peripheral nerves. Spontaneous and P0 peptide 180-199 stimulated proliferation of peripheral T-cells were enhanced by PT-treatment as well. The enhancing effect was lower before onset of the disease (Day 6 post immunization) (p.i.) as compared to the early phase of the disease (Day 22 p.i.). Thus, P0 peptides together with PT are able to break tolerance to myelin in C57BL/6 mice.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Myelin P0 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Pertussis Toxin,
http://linkedlifedata.com/resource/pubmed/chemical/Virulence Factors, Bordetella
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0360-4012
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2000 Wiley-Liss, Inc.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
717-21
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11104510-Adjuvants, Immunologic,
pubmed-meshheading:11104510-Animals,
pubmed-meshheading:11104510-Inflammation,
pubmed-meshheading:11104510-Lymph Nodes,
pubmed-meshheading:11104510-Mice,
pubmed-meshheading:11104510-Mice, Inbred C57BL,
pubmed-meshheading:11104510-Myelin P0 Protein,
pubmed-meshheading:11104510-Myelin Sheath,
pubmed-meshheading:11104510-Neuritis, Autoimmune, Experimental,
pubmed-meshheading:11104510-Peptide Fragments,
pubmed-meshheading:11104510-Pertussis Toxin,
pubmed-meshheading:11104510-Sciatic Nerve,
pubmed-meshheading:11104510-T-Lymphocytes,
pubmed-meshheading:11104510-Virulence Factors, Bordetella
|
pubmed:year |
2000
|
pubmed:articleTitle |
P0 protein peptide 180-199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice.
|
pubmed:affiliation |
Division of Geriatric Medicine, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|